Brief Summary

The main purpose of this study is to explore experiences and understand the unmet needs of people with Type 2 Diabetes (T2D) among those who are being managed with basal insulin and those who are insulin naïve in order to understand perspectives for a once weekly insulin option; including any potential barriers to being managed with insulin therapy overall. Study participants will be recruited to complete a 15-minute self-administered online survey.

Trial Health

On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment

700

participants targeted

Target at P75+ for all trials

Timeline

Completed

Started Mar 2023

Shorter than P25 for all trials

Geographic Reach

7 countries

7 active sites

Status

completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

21 days study duration

First Submitted

Initial submission to the registry

February 10, 2023

Completed

11 days until next milestone

First Posted

Study publicly available on registry

February 21, 2023

Completed

1 month until next milestone

Study Start

First participant enrolled

March 27, 2023

Completed

21 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 17, 2023

Completed

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 17, 2023

Completed

Last Updated

May 15, 2023

Status Verified

May 1, 2023

Enrollment Period

21 days

First QC Date

February 10, 2023

Last Update Submit

May 12, 2023

Conditions

Type 2 Diabetes

Outcome Measures

Primary Outcomes (5)

Current medication burden
Numerical; Multiple select from defined list
At the time of survey response (Day1)
Injection perceptions
Likert scale for measurement of agreement from 1 "strongly disagree" to 7 "strongly agree"
At the time of survey response (Day1)
Attitudes regarding T2D overall
Likert scale for measurement of agreement from 1 "strongly disagree" to 7 "strongly agree"
At the time of survey response (Day1)
Attitudes regarding T2D treatment
Likert scales for measurement of satisfaction from 1 "extremely unsatisfied" to 7 "extremely satisfied" and agreement from 1 "strongly disagree" to 7 "strongly agree"
At the time of survey response (Day1)
Attitudes regarding insulin icodec
Likert scales for measurement of likelihood from 0 "not at all likely" to 10" extremely likely" and agreement from 1 "strongly disagree" to 7 "strongly agree; Rank top 3 from defined list
At the time of survey response (Day1)

Study Arms (1)

People with Type 2 Diabetes

Participants are recruited via email through online panel companies

Other: No treatment given

Interventions

No treatment givenOTHER

No treatment given

People with Type 2 Diabetes

Eligibility Criteria

Age18 Years - 65 Years

Sexall

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

The main purpose of this study is to explore experiences and understand the unmet needs of people with Type 2 Diabetes among those who are being managed with basal insulin and those who are insulin naïve in order to understand perspectives for a once weekly insulin option; including any potential barriers to being managed with insulin therapy overall.

You may qualify if:

Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
Male or female, age above or equal between 18 to 65 years at the time of signing informed consent.
Diagnosed with T2D and currently treating T2D with at least one medication
Insulin user that is not using insulin pump
Lives in a target country

You may not qualify if:

Previous participation in this study. Participation is defined as having given informed consent in this study
Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation

Contact the study team to confirm eligibility.